Clinical Trial

A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of the study is to find out if NNC0662-0419 is safe and effective for treating participants living with obesity.
Trial Details
NCT Number NCT07639021
Lead Sponsor Novo Nordisk A/S
Conditions Obesity
Enrollment 230 participants
Start Date 2026-06-09
Primary Completion 2027-07-12 (estimated)
Study Completion 2027-07-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-10